Levetiracetam 27808-0263-02
- Manufacturer
- Cranbury Pharmaceuticals, Llc
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- May 1, 2023
- Listing Expires
- December 31, 2026
- Application
- ANDA091491
Need to source Levetiracetam? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Levetiracetam | 250 mg/1 |
Drug Class
Decreased Central Nervous System Disorganized Electrical Activity [PE]
Selected Package
27808-0263-02Selected500 TABLET in 1 BOTTLE (27808-263-02)
Other packages for this product(1)
120 TABLET in 1 BOTTLE (27808-263-01)